Results 191 to 200 of about 219,244 (264)

Progressive myoclonus epilepsy in Down syndrome with Alzheimer's disease: An 11‐year longitudinal study and proposed diagnostic red flags

Epilepsia Open, EarlyView.
Abstract Objective Individuals with Down syndrome (DS) face an ultra‐high risk of Alzheimer's disease (AD). Within this continuum, Progressive Myoclonus Epilepsy (PME) has emerged as a marker of advanced neurodegeneration. Building on our 2014 characterization of this syndrome, we aimed to define its long‐term natural history and pathological substrate.
Giuseppe d'Orsi, Ezio Calò, Maria Teresa Di Claudio, Carmela Pia Ferro, Umberto Costantino, Elio Perrone, Raffaela Rita Latino   +6 more
wiley   +1 more source

Causal effects of mental disorders on stroke subtypes: A proteome-wide Mendelian randomization and mediation analysis. [PDF]

Medicine (Baltimore)
Cong L, Ji H, Yang H, Kuang G, Liu H, Sun H, Liu Y.   +6 more
europepmc   +1 more source

Beyond seizures: A multidimensional approach to non‐seizure issues in Lennox–Gastaut syndrome. Insights from Italian experts

Epilepsia Open, EarlyView.
Abstract Non‐seizure issues (NSIs), including cognition, behavior/psychiatric symptoms, adaptive and social functioning, sleep, autonomic, and motor impairments, often shape day‐to‐day outcomes in Lennox–Gastaut syndrome (LGS) more than seizures, yet clinicians lack LGS‐specific, feasible assessment pathways.
Giancarlo Di Gennaro, Domenica Immacolata Battaglia, Paolo Bonanni, Gian Marco Duma, Antonietta Coppola, Edoardo Ferlazzo, Dario Pruna, Carlo Di Bonaventura   +7 more
wiley   +1 more source

Dietary Carbohydrates and ADHD Symptoms: A Systematic Review. [PDF]

Nutrients
Panayotova GG, Hachmeriyan A.
europepmc   +1 more source

Association between child ADHD and caregivers' mental health and health-related quality of life: results from a population-based study. [PDF]

Qual Life Res
Le HND, Yee R, Dona SWA, Silk T.
europepmc   +1 more source

Correction: An Open‑Label Extension Study Assessing the Long‑Term Safety and Efficacy of Viloxazine Extended‑Release Capsules in Adults with Attention‑Deficit/Hyperactivity Disorder. [PDF]

CNS Drugs
Childress A, Cutler AJ, Adler LA, Fry N, Asubonteng K, Maldonado-Cruz Z, Formella A, Rubin J.   +7 more
europepmc   +1 more source

Educators' knowledge of and attitudes towards attention deficit hyperactivity disorder. [PDF]

J Coll Med S Afr
Mello LLC, Naicker D, van der Westhuizen D.   +2 more
europepmc   +1 more source

Environmental Exposures and Neuroimaging in Children with Neurodevelopmental Disorders: A Scoping Review. [PDF]

Curr Environ Health Rep
Rechtman E, Rebello V, Invernizzi A, Sather A, Oluyemi K, Rodriguez MA, Horton M.   +6 more
europepmc   +1 more source

Attention-Deficit/Hyperactivity Disorder, Racial Disparities, and Involvement in the Juvenile Justice System: A Narrative Review. [PDF]

Cureus
Atkins JB, Toro Ruilowa OA, Chea D, Chen C.   +3 more
europepmc   +1 more source